title: Access to medicines versus access to treatment: the case of type 1 diabetes.
authors.affiliation: International Insulin Foundation, London, England.
authors.forename: David
authors.initials: D
authors.lastname: Beran
authors.forename: Ariane
authors.initials: A
authors.lastname: McCabe
authors.forename: John S
authors.initials: JS
authors.lastname: Yudkin
mesh_terms: D000349:Africa; D002908:Chronic Disease / Q000188:drug therapy*; D003906:Developing Countries / Q000191:economics; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D016527:Drug Costs; D004345:Drug Industry; D018954:Drugs, Essential / Q000191:economics* / Q000600:supply & distribution; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D006297:Health Services Accessibility / Q000191:economics* / Q000941:ethics / Q000458:organization & administration; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use; D007328:Insulin / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use
chemical_list: D018954:Drugs, Essential; D016568:Drugs, Generic; D007004:Hypoglycemic Agents; D007328:Insulin
references.citation: Lancet. 1997 May 10;349(9062):1347-52
references.pmid: 9149696
references.citation: Bull World Health Organ. 2007 Apr;85(4):279-88
references.pmid: 17546309
references.citation: BMC Health Serv Res. 2006 Feb 24;6:17
references.pmid: 16504123
references.citation: Diabetes Care. 2005 Sep;28(9):2136-40
references.pmid: 16123479
references.citation: Lancet. 2006 Nov 11;368(9548):1689-95
references.pmid: 17098088